|
Jul 28
|
Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025
|
|
May 28
|
High Growth Tech Stocks In Europe May 2025
|
|
May 27
|
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
|
|
Feb 27
|
BioInvent International AB: Year-End Report January 1 - December 31, 2024
|
|
Feb 25
|
Invitation to Presentation of BioInvent's Year-end Report 2024
|